Indication
Pellagra
Pellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production. Read more about Pellagra
25 drugs 18 manufacturers
Drugs that treat it
Common Pellagra therapies.
NIACINAMIDE
NIACINAMIDE
NO FLUSH NIACIN (niacin (inositol niacinate))
NIACIN FLUSH FREE (niacin (inositol niacinate))
NIACIN INOSITOL (niacin (inositol niacinate))
NIACIN
NIACIN FLUSH-FREE (niacin (inositol niacinate))
NIACIN FLUSH FREE (niacin (inositol niacinate))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production.
Primarily affecting the cutaneous, gastrointestinal, and central nervous systems, it is observed in populations with inadequate dietary intake, chronic alcoholism, malabsorption disorders, or metabolic disruptions such as carcinoid syndrome or specific drug interactions.
Pathophysiologically, the condition is classically characterized by a triad often referred to as the "three Ds": photosensitive, symmetrical, hyperkeratotic dermatitis, persistent diarrhea, and neurocognitive impairment or encephalopathy, which can ultimately be fatal if left untreated.
- nih.gov
Pellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production Pathophysiologically, the condition is classically characterized by a triad often referred to as the "three Ds": photosensitive, symmetrical, hyperkeratotic dermatitis, persistent diarrhea, and neurocognitive impairment or encephalopathy, which can ultimately be fatal if left untre...
- nih.gov
Pellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production Primarily affecting the cutaneous, gastrointestinal, and central nervous systems, it is observed in populations with inadequate dietary intake, chronic alcoholism, malabsorption disorders, or metabolic disruptions such as carcinoid syndrome or specific drug interactions Pathophysio...
- nih.gov
Pellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production
- nih.gov
Primarily affecting the cutaneous, gastrointestinal, and central nervous systems, it is observed in populations with inadequate dietary intake, chronic alcoholism, malabsorption disorders, or metabolic disruptions such as carcinoid syndrome or specific drug interactions
- dermnetnz.org
Primarily affecting the cutaneous, gastrointestinal, and central nervous systems, it is observed in populations with inadequate dietary intake, chronic alcoholism, malabsorption disorders, or metabolic disruptions such as carcinoid syndrome or specific drug interactions
- nih.gov
Pathophysiologically, the condition is classically characterized by a triad often referred to as the "three Ds": photosensitive, symmetrical, hyperkeratotic dermatitis, persistent diarrhea, and neurocognitive impairment or encephalopathy, which can ultimately be fatal if left untreated
Personalize your experience
Follow Pellagra and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.